Can subcutaneous anastrozole lower estradiol too much in a premenopausal female? A 4-8 mg dose of anastrozole (aromatase inhibitor) implant, releasing over 90 days, does not suppress ovarian estradiol production in premenopausal women. Its main function is to modulate peripheral aromatization, maintaining stable estradiol levels in target tissues such as the brain and uterus, without altering gonadotropin levels (FSH, LH). As a result, symptoms of estrogen deficiency, like hot flashes or vaginal dryness, are neither expected nor observed, particularly when low-dose anastrozole is paired with testosterone replacement therapy in premenopausal patients. Given the natural fluctuations in premenopausal hormone levels, routine…

Testosterone Therapy & Autoimmune Health Support for Rheumatoid Arthritis (RA) and Related Conditions Anti-Inflammatory Benefits Calms the immune system: less swelling, stiffness, and pain Lowers harmful cytokines, which slows joint damage Promotes healthy immune balance